source
- Gene-editing biotech Scribe Therapeutics files for Nasdaq IPOScribe Therapeutics, a California-based biotechnology startup developing genetic medicines for cardiometabolic disorders, announced plans to go public on the Nasdaq under the ticker SCTX. The comp…
- Abiomed recalls Impella CP Sets with SmartAssist over low purge pressure riskAbiomed has issued a recall of specific Impella CP Sets with SmartAssist after discovering that the units do not meet design specifications. The defect can cause low purge pressure events from the…